Opinion

Your Fasting Glucose Is Slowly Killing You — And the 'Normal' Range Is the Cover-Up

SC
Dr. Sarah Chen · January 15, 2026 · 7 min read

The medical establishment drew the line at 100 mg/dL because it's convenient — not because it's optimal. If you care about your healthspan, you need to be under 90. Period.

I got my fasting glucose result back last year: 94 mg/dL. My doctor circled it in green. "Perfectly normal," she said. I smiled, nodded, and went home to do something my doctor didn't do — I read the actual longevity research.

Here's what I found: the "normal" fasting glucose range of 70–99 mg/dL is a compromise. It was set by committee. It reflects the threshold where diabetes risk starts climbing sharply — not the level where you're actually optimizing for decades of metabolic health. There's a world of difference between "not diabetic" and "metabolically thriving."

I've spent the last decade studying metabolic health and aging biomarkers. And I'm going to tell you something that might make you uncomfortable: if your fasting glucose is between 90 and 99, you are not fine. You're in the zone where the damage is already happening — slowly, invisibly, and with the full blessing of your healthcare provider.

The number you should care about isn't 100. It's 90. And ideally, it's lower than that.

"The difference between a fasting glucose of 85 and 95 isn't 10 points. It's the difference between metabolic resilience and metabolic drift."

The Research Nobody Talks About

Let's start with the data that changed my mind. A 2019 meta-analysis published in the Journal of the American College of Cardiology looked at over 1.8 million participants across 26 studies. The finding was stark: cardiovascular risk begins to increase at a fasting glucose of just 86 mg/dL — a full 14 points below the "prediabetic" threshold.

Read that again. Not at 100. Not at 110. At 86.

Every point above 86 was associated with incrementally higher risk of heart disease, stroke, and all-cause mortality. The curve doesn't wait for you to cross some magical line at 100. The damage starts in the 80s.

Then there's the work from the Whitehall II study — one of the largest longitudinal cohort studies ever conducted, tracking British civil servants for over 30 years. They found that fasting glucose in the high-normal range (95–99) was associated with a 40% increased risk of cardiovascular death compared to those in the 70–84 range. Not prediabetic. Not diabetic. "Normal."

The PURE study — 125,000+ participants across 21 countries — confirmed the pattern. Fasting glucose above 90 mg/dL predicted significantly higher rates of major cardiovascular events, even after controlling for every confounder the researchers could identify.

"Cardiovascular risk begins climbing at 86 mg/dL — 14 points below the prediabetic threshold. The damage starts in the 80s."

The Population Nobody Studies

Here's something I find genuinely fascinating: when researchers look at populations with exceptional longevity — centenarians, Blue Zone communities, elite endurance athletes — their fasting glucose clusters in a very specific range. It's not 95. It's not 90. It's typically between 70 and 85 mg/dL.

Dr. Valter Longo's research at USC on fasting-mimicking diets found that participants who maintained fasting glucose in the low 80s showed the most favorable aging biomarkers: lower IGF-1, reduced inflammatory markers, improved insulin sensitivity. The sweet spot wasn't "under 100." It was under 85.

And yet — and this is the part that keeps me up at night — we tell the person with a fasting glucose of 97 that they're "perfectly normal." We tell them to come back in a year. We don't mention that they're sitting in the exact range where metabolic dysfunction is quietly accelerating their aging.

Why the Line Got Drawn at 100

The fasting glucose threshold of 100 mg/dL for "normal" wasn't derived from longevity data. It was derived from diabetes risk curves. The ADA chose 100 because it roughly identified the inflection point where type 2 diabetes risk begins to skyrocket. It's a disease threshold, not an optimization threshold.

There's a massive difference between asking "At what level does disease risk explode?" and asking "At what level is aging optimized?" The medical establishment answered the first question. We need to answer the second.

This is the fundamental problem with preventive medicine in America: we define health as the absence of diagnosable disease. By that standard, a fasting glucose of 99 is "healthy." But by any longevity-informed standard — the standard that asks how well your body will function at 70, 80, 90 — 99 is already a warning sign.

"We define health as the absence of diagnosable disease. By that standard, 99 mg/dL is 'healthy.' By any longevity standard, it's a warning sign."

The Mechanism Is Simple

You don't need a PhD in biochemistry to understand why this matters. Chronically elevated glucose damages blood vessels. It glycates proteins — a process where sugar molecules bind to proteins and create advanced glycation end-products (AGEs). These AGEs stiffen arteries, damage kidneys, degrade collagen in your skin, and contribute to the chronic inflammation that drives virtually every age-related disease.

This process doesn't wait for a diagnosis. It's happening right now, at whatever your fasting glucose is. The question is the rate. At 82 mg/dL, glycation is slow enough that your body's repair mechanisms can keep up. At 95, you're losing that race. Year after year, the damage accumulates.

And here's what really got my attention: fasting glucose doesn't exist in isolation. A fasting glucose of 95 almost always comes with elevated fasting insulin, increasing HbA1c, and deteriorating insulin sensitivity. It's not one number — it's a direction. And the direction, for most people sitting in the 90s, is wrong.

The Protocol Is Straightforward

If your fasting glucose is above 90, here's what I'd do — and what the evidence supports:

The goal is simple: get your fasting glucose into the 70–85 range and keep it there.

"At 82, glycation is slow enough that your repair mechanisms keep up. At 95, you're losing that race. Year after year, the damage accumulates."

The Counterargument

I know what some of you are thinking: "This is just one person's interpretation. The guidelines say under 100 is fine. Who are you to disagree?"

Fair question. Here's my answer: the guidelines are designed for population-level diabetes screening, not individual longevity optimization. They're a floor, not a ceiling. And the evidence from every major longevity study — the Whitehall II, PURE, EPIC-Norfolk, and Longo's fasting research — consistently points to the same conclusion: lower is better, within the normal physiological range, and the real sweet spot is in the low 80s.

The argument that "we need more evidence before changing guidelines" is the same argument that delayed action on smoking by 30 years and trans fats by 20. We have the data. We've had it for years. The fact that the medical establishment hasn't updated the threshold doesn't mean the threshold is right. It means change is slow.

In the meantime, 73% of American adults are overweight or obese. Over 50% have prediabetes or diabetes. The current guidelines aren't working. Maybe it's time to stop optimizing for the average and start optimizing for the exceptional.

Here's My Challenge to You

Get your fasting glucose tested this week. Not next month. This week. And when you get the result, don't ask your doctor if it's "normal." Ask yourself a harder question:

"Is this number going to keep me sharp, strong, and independent at 80 — or is it going to put me in a cardiologist's office at 60?"

The 90s aren't a safe harbor. They're the beginning of a slow metabolic decline that compounds every single year. You can accept "normal." Or you can demand optimal.

What are you going to do about it?

One uncomfortable metabolic truth, weekly.

No fluff. No supplement shilling. Just evidence-tiered insights that challenge the standard narrative.

Join 4,200+ men · No spam · Unsubscribe anytime

SC

Dr. Sarah Chen

Metabolic Health Researcher · PhD Biochemistry, Stanford

Former clinical researcher at the Buck Institute for Research on Aging. She's spent 12 years studying glucose metabolism, insulin signaling, and the biomarkers that actually predict how well you'll age. She writes about what the data says — not what the wellness industry sells.

Read more from Sarah →
Share this take:

Get Takes Like This Weekly

Evidence-tiered metabolic health insights that challenge the standard narrative. No fluff, no supplement pitches.

4,200+ subscribers · Unsubscribe anytime